Addressing Cisplatin and Carboplatin Shortages: Insights from FDA Oncology Center of Excellence Director

Addressing Cisplatin and Carboplatin Shortages: Insights from FDA Oncology Center of Excellence Director

In this open access discussion, Richard Pazdur, Director of the FDA Oncology Center of Excellence, sheds light on the root causes of the cisplatin and carboplatin shortages and proposes potential solutions to alleviate the issue.

https://cancerletter.com/conversation-with-the-cancer-letter/20230530_1/

Source:

carboplatin Cisplatin FDA Oncology Center Kirsten Boyd Goldberg Richard Pazdur